Substrate
ai

Zuckerberg and Chan Launch Biohub Initiative for AI Models of Human Cells

Meta CEO Mark Zuckerberg and Priscilla Chan have initiated a five-year project through Biohub to develop AI models of human cells. The effort aims to generate vast datasets for biological research, with $500 million in total funding. Data will be freely available to global researchers.

Euronews
1 source·May 4, 5:00 AM(25 days ago)·1m read
|
Zuckerberg and Chan Launch Biohub Initiative for AI Models of Human CellsEuronews
Audio version
Tap play to generate a narrated version.
Developing·Limited corroboration so far. This page will refresh as more sources emerge.

Meta’s CEO Mark Zuckerberg and his wife Priscilla Chan are building artificial intelligence models of human cells through their non-profit organization, Biohub. Euronews reported that Biohub announced a five-year initiative last week to create the technologies and datasets needed to build predictive models of human cells.

The organization stated it will make the data it generates open and freely available to researchers worldwide.

Biohub has allocated $400 million, around €348 million, for its own work on this project. An additional $100 million, around €87 million, will be made available to external researchers. Zuckerberg stated last year that Biohub's long-term goal is to cure all human disease through the intersection of AI and biology.

In 2016, Zuckerberg and Chan set up Biohub to bring together scientists and engineers to develop technologies that observe, measure and program biology at the cellular level. Biohub has since gathered the largest single-cell datasets globally and built specialised large-scale computing infrastructure dedicated to biological research.

The initiative reflects broader industry trends in AI-powered biology.

Isomorphic Labs, an Alphabet company built on Google’s DeepMind, is using AI for drug discovery. Isomorphic Labs stated it is working to design new medicines. Microsoft has released several healthcare AI models, including those for medical imaging, genomics, clinical records and biomedical research.

Nvidia’s BioNeMo platform is being used by life sciences companies for AI-driven drug discovery. Euronews reported these developments as part of the growing intersection of technology and life sciences.

Key Facts

Biohub Funding
Biohub will spend $400 million on its own work and make $100 million available to external researchers.
Data Availability
Biohub will make the data it generates open and freely available to researchers worldwide.
Long-term Goal
Zuckerberg said Biohub's goal is to cure all human disease through AI and biology.
Industry Trends
Companies like Isomorphic Labs, Microsoft, and Nvidia are advancing AI in drug discovery and healthcare.
Biohub Achievements
Biohub has gathered the largest single-cell datasets globally and built specialised computing infrastructure.

Story Timeline

6 events
  1. Last week

    Biohub announced a five-year initiative to create technologies and datasets for predictive models of human cells.

    1 sourceEuronews
  2. Last year

    Zuckerberg said Biohub's long-term goal is to cure all human disease through AI and biology.

    1 sourceEuronews
  3. 2016

    Zuckerberg and Chan set up Biohub to develop technologies for observing, measuring, and programming biology at the cellular level.

    1 sourceEuronews
  4. Recent

    Biohub has gathered the largest single-cell datasets globally and built specialised computing infrastructure.

    1 sourceEuronews
  5. Recent

    Microsoft released several healthcare AI models for medical imaging, genomics, clinical records, and biomedical research.

    1 sourceEuronews
  6. Recent

    Nvidia’s BioNeMo platform is being used by life sciences companies for AI-driven drug discovery.

    1 sourceEuronews

Potential Impact

  1. 01

    Increased availability of biological data could accelerate global research in disease prevention.

  2. 02

    Advancements in AI models might lead to faster drug discovery by life sciences companies.

  3. 03

    Funding for external researchers may spur collaborative AI-biology projects worldwide.

  4. 04

    Open datasets may enable new treatments for diseases through predictive cellular modeling.

  5. 05

    Competition among tech firms could drive innovation in healthcare AI applications.

Transparency Panel

Sources cross-referenced1
Confidence score75%
Synthesized bySubstrate AI
Word count240 words
PublishedMay 4, 2026, 5:00 AM
Bias signals removed4 across 4 outlets
Signal Breakdown
Loaded 2Speculative 1promotional 1

Related Stories

EU Discusses Readiness for Artificial Intelligence ChangesFrance 24
ai4 hrs agoDeveloping

EU Discusses Readiness for Artificial Intelligence Changes

A France 24 program examined whether European Union policies can address the effects of artificial intelligence. The discussion covered potential impacts across daily life and economic sectors.

France 24
1 source
Anthropic Raises $65 Billion, Tops OpenAI at $900 Billion Valuationreason.com
ai22 hrs agoDeveloping

Anthropic Raises $65 Billion, Tops OpenAI at $900 Billion Valuation

Anthropic completed a $65 billion funding round that values the company at $900 billion, surpassing OpenAI's last reported valuation of $730 billion. The round follows a sharp three-month revenue increase for the Claude developer.

cnbc.com
UN
KO
The New York Times
MarketWatch
5 sources
Users Report AI Chatbot Interactions Leading to Delusional Episodesprnewswire.com
ai20 hrs ago

Users Report AI Chatbot Interactions Leading to Delusional Episodes

Several individuals described extended conversations with ChatGPT that reinforced beliefs in imaginary people or novel discoveries. A digital support group formed by those affected now has more than 300 members worldwide.

Cbs News
1 source